Thymus Cancer Market, By Type (Thymoma and Thymic Carcinoma), By Stage (Stage I, Stage II, Stage III, and Stage IV), By Therapy Type (Chemotherapy (Alkylating Agents (e.g., Cyclophosphamide and Cisplatin), Antimetabolites (e.g., Pemetrexed), and Corticosteroids (e.g., Prednisone)), Targeted Therapy (mTOR Inhibitors (e.g., Everolimus) and Tyrosine Kinase Inhibitors (e.g., Sunitinib)), Immunotherapy, (Immune Checkpoint Inhibitors (e.g., Pembrolizumab), Hormonal Therapy (Somatostatin Analogs (e.g., Octreotide)), and Supportive Care (Growth Factors (e.g., G-CSF), Antiemetics, and Analgesics)), By Route of Administration (Oral, Parenteral, and Others), By Age Group (Pediatric, Adult, and Geriatric), By Gender (Male and Female), By End User (Hospitals, Specialty Cancer Centers, Ambulatory Surgical Centers, and Research and Academic Institutes), By Distribution Channel (Hospital pharmacies, Retail pharmacies, and Online pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)